Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and teenagers aged between 2 and 17 years and 11 months old
- People who have been diagnosed with type 1 diabetes for at least 3 months but no more than 6 months, based on World Health Organization standards
- People who have tested positive for at least one of the following diabetes-related markers in their blood: anti-GAD, anti-IA2, anti-ZnT8, or anti-insulin antibodies
- People who are currently managing their diabetes using multiple daily insulin injections or an insulin pump (including pumps that can pause automatically if low blood sugar is predicted)
- The patient and/or their parents or guardians must have been trained in counting carbohydrates in food
- The patient and/or their parents or guardians must own a smartphone that supports the Dexcom G6 app, and those involved must be willing to use the Dexcom G6 sensor and app for the entire duration of the study
Who may not be able to join:
- Cases where a parent or legal guardian is unwilling to be involved in the child's insulin treatment
- People who have another ongoing long-term condition or are taking medications (other than insulin or a stable dose of L-thyroxine) that affect blood sugar levels
- People who are already using a fully automated insulin delivery system that connects an insulin pump to a continuous glucose monitor with a control algorithm (also called a hybrid closed-loop system)
- People who have a skin allergy or skin reaction to the adhesives used in glucose monitors or insulin pods
- People who have vision or hearing difficulties that would prevent them from using all the features of the Omnipod 5 system, including its alerts and alarms
- Cases where the patient and/or their parents or legal guardian have cognitive or psychological difficulties that may make it hard to follow the study procedures reliably
- People who are currently enrolled in another clinical trial or who have received an unapproved medication within the 4 weeks before the screening date
- People who have an employment or dependent relationship with the organisation running or sponsoring the trial
- Cases where the patient and their parents or legal guardian have not signed the required consent form
- People who would be unable to attend all required appointments or follow all trial procedures
- People who are under legal protection or who have had their liberty restricted by law
- People who are pregnant or breastfeeding
- People who are not covered by public health insurance
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eric RENARD, MD, University Hospital, Montpellier
Phone: 04 67 33 83 82
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glycated hemoglobin (HbA1c) level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.